Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and MDM2 Amplification
MDM2 与靶向激酶抑制剂联合使用可延长具有致癌酪氨酸激酶驱动和 MDM2 扩增的肺腺癌的肿瘤控制时间
期刊:Jco Precision Oncology
影响因子:5.3
doi:10.1200/PO.24.00241
Arielle Elkrief, Igor Odintsov, Roger S Smith, Morana Vojnic, Takuo Hayashi, Inna Khodos, Vladimir Markov, Zebing Liu, Allan J W Lui, Jamie L Bloom, Michael D Offin, Charles M Rudin, Elisa de Stanchina, Gregory J Riely, Romel Somwar, Marc Ladanyi
